Insider filing · AVTX
Mittie Doyle
Chief Medical Officer
profile →
Avalo Therapeutics, Inc.
AVTX · Healthcare · 11 filings in 24 months
ticker →
Mittie Doyle sold $412K of Avalo Therapeutics (AVTX)
Executed Mar 16, disclosed Mar 18, 2 days later.
Value, as filed
$412K
25,492 sh × $16.15
Executed
Mar 16
the trade date, as filed
Disclosed
Mar 18
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MDMittie Doyle (Chief Medical Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Avalo Therapeutics, Inc. (AVTX). The largest single filing was $2.1M of AVTX (101,555 sh across 4 lots, as filed), executed May 6.
The name
AVTXHealthcare · Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Mittie Doyle in AVTX
AVTXSALE
Avalo Therapeutics, Inc.
$2.1M101,555 sh across 4 lots
Exec May 6
Filed May 7 · 5:30 PM ET